Drug intelligence / Profile preview

He Yan Danggui Yixue Oral Liquid

Development stage: Unknown
Lead developer: Xintian Pharmaceutical
Modality: Small Molecules
Administration: Oral

Overview

He Yan Danggui Yixue Oral Liquid is a Traditional Chinese Medicine (TCM) product developed and manufactured by Guiyang Xintian Pharmaceutical. Formulated as an oral liquid, it is primarily indicated for the treatment of blood deficiency symptoms, including anemia, dizziness, palpitations, irregular menstruation, and postpartum blood deficiency. The preparation is based on traditional herbal principles, prominently featuring *Angelica sinensis* (Danggui), which is traditionally used in Chinese medicine to enrich the blood, promote circulation, and regulate menstruation. It is currently approved and marketed in China for these indications.

Brand names: He Yan和颜
Other names: Danggui Yixue Oral Liquid当归益血口服液和颜当归益血口服液

Beyond the preview

Go deeper on He Yan Danggui Yixue Oral Liquid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on He Yan Danggui Yixue Oral Liquid.

Explore the full profile